Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Clinical, digital and business leaders from around Boston Children’s Hospital offered their forecasts for the science and clinical innovations that will have the biggest impact on healthcare in 2016.
Curiosity is a critical yet underrated skill for 21st century healthcare innovation, according to a post on the HL7 blog authored by a writer known as HealthIsCool.
The Centers for Medicare and Medicaid Services (CMS) recently announced a initiative that may help some health systems address patients’ health-related social needs.
The Affordable Care Act is swelling patient rolls while CMS continues slapping EMR-resistant providers with increasingly hefty financial penalties. What’s an already overburdened doctor to do?
Redmond Burke, MD, used an iPhone and Google Cardboard, a virtual reality tool, to successfully operate on a baby girl previously dismissed as impossible to save.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.